Myriad Genetics (MYGN) News Today $8.12 +0.05 (+0.56%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Myriad Genetics price target lowered to $9 from $11 at BofAApril 15 at 3:12 AM | markets.businessinsider.comMyriad Genetics (MYGN) Sees Price Target Lowered by BofA Amid Policy Concerns | MYGN Stock NewsApril 14 at 11:12 AM | gurufocus.comTrexquant Investment LP Decreases Position in Myriad Genetics, Inc. (NASDAQ:MYGN)Trexquant Investment LP lowered its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 31.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 92,376 shares of the company's stock after selling 42,569April 12 at 4:43 AM | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Upgraded by StockNews.com to Buy RatingStockNews.com upgraded shares of Myriad Genetics from a "hold" rating to a "buy" rating in a research report on Thursday.April 12 at 2:44 AM | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Cut to "Neutral" at GuggenheimApril 12 at 2:35 AM | americanbankingnews.comMyriad Genetics (NASDAQ:MYGN) Shares Gap Down - Should You Sell?Myriad Genetics (NASDAQ:MYGN) Shares Gap Down - Time to Sell?April 11, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Stock Rating Lowered by GuggenheimGuggenheim cut shares of Myriad Genetics from a "buy" rating to a "neutral" rating in a research report on Wednesday.April 11, 2025 | marketbeat.comGuggenheim Downgrades Myriad Genetics (MYGN)April 10, 2025 | msn.comMyriad Genetics downgraded to Neutral from Buy at GuggenheimApril 9, 2025 | markets.businessinsider.comMyriad Genetics (NASDAQ:MYGN) Hits New 52-Week Low - Time to Sell?Myriad Genetics (NASDAQ:MYGN) Hits New 12-Month Low - Time to Sell?April 9, 2025 | marketbeat.comVanguard Group Inc. Boosts Stock Position in Myriad Genetics, Inc. (NASDAQ:MYGN)Vanguard Group Inc. boosted its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 2.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,591,043 shares of the company's stock afApril 9, 2025 | marketbeat.comMyriad Genetics, Inc.: Myriad Genetics Names Brian Donnelly as New Chief Commercial OfficerApril 8, 2025 | finanznachrichten.deMyriad Genetics Announces Inducement AwardsApril 8, 2025 | globenewswire.comMyriad Genetics appoints Brian Donnelly as CCOApril 8, 2025 | markets.businessinsider.comMyriad Genetics Names Brian Donnelly as New Chief Commercial OfficerApril 7, 2025 | gurufocus.comMyriad Genetics Names Brian Donnelly as New Chief Commercial OfficerApril 7, 2025 | globenewswire.comWellington Management Group LLP Sells 711,985 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Wellington Management Group LLP lowered its position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 10.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,004,598 shares of the company's stock after selling 711,985April 7, 2025 | marketbeat.comPictet Asset Management Holding SA Cuts Stake in Myriad Genetics, Inc. (NASDAQ:MYGN)Pictet Asset Management Holding SA lessened its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 7.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 479,808 shares of the company's stock after selling 36,262 shares during theApril 5, 2025 | marketbeat.comPrudential Financial Inc. Sells 126,550 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Prudential Financial Inc. lessened its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 37.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 209,131 shares of the company's stockApril 4, 2025 | marketbeat.com10 Analysts Assess Myriad Genetics: What You Need To KnowApril 3, 2025 | nasdaq.comMyriad Genetics (NASDAQ:MYGN) Cut to Hold at StockNews.comStockNews.com downgraded Myriad Genetics from a "buy" rating to a "hold" rating in a report on Wednesday.April 3, 2025 | marketbeat.comScotiabank Lowers Myriad Genetics (NASDAQ:MYGN) Price Target to $20.00Scotiabank decreased their target price on shares of Myriad Genetics from $24.00 to $20.00 and set a "sector outperform" rating for the company in a research note on Tuesday.April 2, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Sets New 12-Month Low - What's Next?Myriad Genetics (NASDAQ:MYGN) Hits New 52-Week Low - What's Next?April 2, 2025 | marketbeat.comMyriad Genetics, Inc. (NASDAQ:MYGN) Receives Consensus Rating of "Hold" from AnalystsShares of Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) have earned a consensus rating of "Hold" from the fifteen analysts that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and six have gApril 2, 2025 | marketbeat.comMyriad Genetics price target lowered to $20 from $24 at ScotiabankApril 1, 2025 | markets.businessinsider.comMyriad Genetics (MYGN) Receives a Buy from ScotiabankApril 1, 2025 | markets.businessinsider.com6MYGN : 10 Analysts Assess Myriad Genetics: What You Need To KnowApril 1, 2025 | benzinga.comArtisan Partners Limited Partnership Buys 336,770 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Artisan Partners Limited Partnership raised its position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 13.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 2,766,729 shares of the company's stock after buying an additional 336,770 shares duMarch 30, 2025 | marketbeat.comSegall Bryant & Hamill LLC Purchases 41,739 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Segall Bryant & Hamill LLC boosted its position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 137.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 72,117 shares of the company's stock after buying an additiMarch 30, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Hits New 52-Week Low - What's Next?Myriad Genetics (NASDAQ:MYGN) Sets New 12-Month Low - Here's WhyMarch 27, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Raised to "Buy" at StockNews.comStockNews.com raised shares of Myriad Genetics from a "hold" rating to a "buy" rating in a research note on Tuesday.March 26, 2025 | marketbeat.comEntryPoint Capital LLC Takes $684,000 Position in Myriad Genetics, Inc. (NASDAQ:MYGN)EntryPoint Capital LLC acquired a new stake in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 49,886 shares of the company's stock, valued at approximately $684,000. EntryPoMarch 26, 2025 | marketbeat.comSei Investments Co. Acquires 174,770 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Sei Investments Co. increased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 7.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,526,761 shares of the company's stock after purchasinMarch 25, 2025 | marketbeat.comNatixis Advisors LLC Sells 110,685 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Natixis Advisors LLC reduced its position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 34.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 209,328 shares of the company's stock after sMarch 24, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 42,233 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)Charles Schwab Investment Management Inc. boosted its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 3.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,125,535 shares of the company'sMarch 21, 2025 | marketbeat.com1 Small-Cap Stock on Our Watchlist and 2 to AvoidMarch 20, 2025 | uk.finance.yahoo.comAmundi Grows Stock Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)Amundi raised its stake in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 175.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 43,978 shares of the company's stock after buying an additional 27,989 sharMarch 20, 2025 | marketbeat.comMyriad Genetics (MYGN): Buy, Sell, or Hold Post Q4 Earnings?March 17, 2025 | msn.comConnor Clark & Lunn Investment Management Ltd. Increases Stock Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)Connor Clark & Lunn Investment Management Ltd. increased its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 377.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 549,456 shares of the company's stock after purchasingMarch 16, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Shares Gap Up - Should You Buy?Myriad Genetics (NASDAQ:MYGN) Shares Gap Up - Time to Buy?March 13, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Raised to Overweight at Piper SandlerPiper Sandler raised Myriad Genetics from a "neutral" rating to an "overweight" rating and lifted their target price for the stock from $11.50 to $12.50 in a research report on Wednesday.March 13, 2025 | marketbeat.comMyriad Genetics (NASDAQ:MYGN) Downgraded by StockNews.com to "Hold"StockNews.com downgraded Myriad Genetics from a "buy" rating to a "hold" rating in a research report on Thursday.March 13, 2025 | marketbeat.comMyriad Genetics upgraded to Overweight from Neutral at Piper SandlerMarch 12, 2025 | markets.businessinsider.comPiper Sandler Upgrades Myriad Genetics (MYGN)March 12, 2025 | msn.comWhy Are Myriad Genetics (MYGN) Shares Soaring TodayMarch 12, 2025 | msn.comMyriad Genetics upgraded at Piper Sandler on balanced risk reward setupMarch 12, 2025 | msn.comAnalyst Sees Bottom For Myriad Genetics Stock, Issues UpgradeMarch 12, 2025 | benzinga.comBuy Rating on Myriad Genetics: Strategic Changes and Growth Potential Amid ChallengesMarch 12, 2025 | tipranks.comMyriad Genetics price target lowered to $16 from $21 at Morgan StanleyMarch 11, 2025 | markets.businessinsider.comMyriad Genetics (NASDAQ:MYGN) Hits New 1-Year Low - Here's What HappenedMyriad Genetics (NASDAQ:MYGN) Hits New 1-Year Low - Should You Sell?March 11, 2025 | marketbeat.com Remove Ads Get Myriad Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for MYGN and its competitors with MarketBeat's FREE daily newsletter. Email Address MYGN Media Mentions By Week MYGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYGN News Sentiment▼0.250.80▲Average Medical News Sentiment MYGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYGN Articles This Week▼167▲MYGN Articles Average Week Remove Ads Get Myriad Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for MYGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FOLD News LGND News BCRX News DVAX News MNKD News CLDX News INVA News NVAX News OPK News GERN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MYGN) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myriad Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myriad Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MYGN Stock Free MYGN Stock Alerts